{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:59:53Z","timestamp":1780340393152,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1842919N"],"award-info":[{"award-number":["1842919N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ejca.2020.03.026","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T19:09:05Z","timestamp":1588273745000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["How to determine kidney function in cancer patients?"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1314-9675","authenticated-orcid":false,"given":"Ben","family":"Sprangers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Abudayyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheron","family":"Latcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-0524","authenticated-orcid":false,"given":"Kenar D.","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2020.03.026_bib1","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/cncr.22904","article-title":"Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study","volume":"110","author":"Launay-Vacher","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2020.03.026_bib2","doi-asserted-by":"crossref","first-page":"9559","DOI":"10.1200\/jco.2009.27.15_suppl.9559","article-title":"Prevalence of renal insufficiency in cancer patients: data from the IRMA-2 study [Abstract]","volume":"27","author":"Janus","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.026_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.ki.5000073","article-title":"Glomerular filtration rate estimated by cystatin C among different clinical presentations","volume":"69","author":"Rule","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejca.2020.03.026_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejca.2020.03.026_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","article-title":"Back SE: measuring GFR: a systematic review","volume":"64","author":"Soveri","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejca.2020.03.026_bib6","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/annonc\/mdm011","article-title":"Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations","volume":"18","author":"Launay-Vacher","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2020.03.026_bib7","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.2018.7260","article-title":"Representation of patients with chronic kidney disease in trials of cancer therapy","volume":"319","author":"Kitchlu","year":"2018","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejca.2020.03.026_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.2014.59.7302","article-title":"Effect of renal dysfunction on toxicity in three decades of cancer therapy evaluation program-sponsored single-agent phase I studies","volume":"34","author":"Beumer","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2020.03.026_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1200\/JCO.19.02138","article-title":"Improving cancer care for patients with chronic kidney disease","volume":"38","author":"Sprangers","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.026_bib10","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1200\/JCO.2005.04.3091","article-title":"Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancer","volume":"24","author":"Raj","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.026_bib11","first-page":"15","article-title":"Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer","volume":"10","author":"Tsao","year":"2012","journal-title":"Clin Genitourin Canc"},{"key":"10.1016\/j.ejca.2020.03.026_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00345-013-1104-5","article-title":"The method of GFR determination impacts the estimation of cisplatin eligibility in patients with advanced urothelial cancer","volume":"32","author":"Horn","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.ejca.2020.03.026_bib13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/cncr.22031","article-title":"Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder","volume":"107","author":"Dash","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2020.03.026_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.urology.2010.03.091","article-title":"Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy","volume":"77","author":"Canter","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.ejca.2020.03.026_bib15","first-page":"e501","article-title":"Are the formulas used to estimate renal function adequate for patients treated with cisplatin-based chemotherapy after nephroureterectomy for upper tract urothelial carcinoma?","volume":"14","author":"Niwa","year":"2016","journal-title":"Clin Genitourin Canc"},{"key":"10.1016\/j.ejca.2020.03.026_bib16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11096-013-9912-7","article-title":"Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?","volume":"36","author":"Bennis","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.ejca.2020.03.026_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1345\/aph.1L446","article-title":"Evaluation of the modified diet in renal disease equation for calculation of carboplatin dose","volume":"43","author":"Shord","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejca.2020.03.026_bib18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ki.2011.322","article-title":"Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Matzke","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejca.2020.03.026_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/0284186X.2014.953259","article-title":"Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer","volume":"54","author":"Stene","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2020.03.026_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000469669","article-title":"Serum creatinine: not so simple!","volume":"136","author":"Delanaye","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.ejca.2020.03.026_bib21","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.cca.2011.07.012","article-title":"A multicentric evaluation of IDMS-traceable creatinine enzymatic assays","volume":"412","author":"Pieroni","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejca.2020.03.026_bib22","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/ndt\/gft006","article-title":"Con: should we abandon the use of the MDRD equation in favour of the CKD-EPI equation?","volume":"28","author":"Delanaye","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejca.2020.03.026_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrneph.2013.143","article-title":"The applicability of eGFR equations to different populations","volume":"9","author":"Delanaye","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejca.2020.03.026_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.ajkd.2012.06.016","article-title":"Accuracy of the MDRD (modification of diet in renal disease) study and CKD-EPI (CKD Epidemiology collaboration) equations for estimation of GFR in the elderly","volume":"61","author":"Kilbride","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejca.2020.03.026_bib25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","article-title":"GFR estimation: from physiology to public health","volume":"63","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejca.2020.03.026_bib26","first-page":"A4236","article-title":"Estimation of kidney function in cancer patients","volume":"58","author":"Redal-Baigorri","year":"2011","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.ejca.2020.03.026_bib27","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/ijc.28816","article-title":"Reliability of estimated glomerular filtration rate in patients treated with platinum containing therapy","volume":"135","author":"Lauritsen","year":"2014","journal-title":"Int J Canc"},{"key":"10.1016\/j.ejca.2020.03.026_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00280-016-2966-1","article-title":"Validity of new methods to evaluate renal function in cancer patients treated with cisplatin","volume":"77","author":"Funakoshi","year":"2016","journal-title":"Canc Chemother Pharmacol"},{"key":"10.1016\/j.ejca.2020.03.026_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2215\/CJN.06470614","article-title":"Estimating GFR in adult patients with hematopoietic cell transplant: comparison of estimating equations with an iohexol reference standard","volume":"10","author":"Hingorani","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejca.2020.03.026_bib30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1054\/bjoc.2000.1643","article-title":"Estimation of glomerular filtration rate in cancer patients","volume":"84","author":"Wright","year":"2001","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejca.2020.03.026_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00432-005-0679-7","article-title":"Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge","volume":"131","author":"Holweger","year":"2005","journal-title":"J Canc Res Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.026_bib32","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2017.72.7578","article-title":"New model for estimating glomerular filtration rate in patients with cancer","volume":"35","author":"Janowitz","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.026_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/j.ajkd.2017.10.005","article-title":"Improving carboplatin dosing based on estimated GFR","volume":"71","author":"Beumer","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejca.2020.03.026_bib34","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1200\/JCO.2003.11.015","article-title":"Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study","volume":"21","author":"Takimoto","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.026_bib35","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ejca.2013.12.021","article-title":"Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma","volume":"50","author":"Shepherd","year":"2014","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2020.03.026_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrclinonc.2013.108","article-title":"Chemotherapy dosing in overweight and obese patients with cancer","volume":"10","author":"Lyman","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.026_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.03.026_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/clinchem\/46.2.193","article-title":"Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy","volume":"46","author":"Stabuc","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejca.2020.03.026_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00280-017-3326-5","article-title":"Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity","volume":"80","author":"Bretagne","year":"2017","journal-title":"Canc Chemother Pharmacol"},{"key":"10.1016\/j.ejca.2020.03.026_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4918325","article-title":"Correlation of serum cystatin C with glomerular filtration rate in patients receiving platinum-based chemotherapy","author":"Cavalcanti","year":"2016","journal-title":"Anal Cell Pathol"},{"key":"10.1016\/j.ejca.2020.03.026_bib41","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1158\/1078-0432.CCR-09-0017","article-title":"A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients","volume":"15","author":"Schmitt","year":"2009","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.ejca.2020.03.026_bib42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000319097","article-title":"Cystatin C as a parameter of glomerular filtration rate in patients with ovarian cancer","volume":"33","author":"Bodnar","year":"2010","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.ejca.2020.03.026_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/172460080001500116","article-title":"Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer","volume":"15","author":"Kos","year":"2000","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.ejca.2020.03.026_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000329354","article-title":"Influence of thyroid function on different kidney function tests","volume":"35","author":"Kimmel","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.ejca.2020.03.026_bib45","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","article-title":"Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement","volume":"65","author":"Knight","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejca.2020.03.026_bib46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2008.638","article-title":"Factors other than glomerular filtration rate affect serum cystatin C levels","volume":"75","author":"Stevens","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejca.2020.03.026_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejca.2006.11.004","article-title":"International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency","volume":"43","author":"Lichtman","year":"2007","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2020.03.026_bib48","series-title":"Clinical practice Guidelines in oncology: older adult oncology version 1","author":"NCCN","year":"2018"},{"key":"10.1016\/j.ejca.2020.03.026_bib49","series-title":"Clinical practice Guidelines in oncology: Adolescent and young adult version 2","author":"NCCN","year":"2017"},{"key":"10.1016\/j.ejca.2020.03.026_bib50","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.2004070549","article-title":"Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function","volume":"16","author":"Froissart","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejca.2020.03.026_bib51","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2020.03.026_bib52","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/annonc\/mdr539","article-title":"Evaluation of glomerular filtration rate estimation by cockcroft-gault, jelliffe, wright and modification of diet in renal disease (MDRD) formulae in oncology patients","volume":"23","author":"Ainsworth","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2020.03.026_bib53","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1592\/phco.31.11.1130","article-title":"Comparative evaluation of the cockcroft-gault equation and the modification of diet in renal disease (MDRD) study equation for drug dosing: an opinion of the nephrology practice and Research Network of the American college of clinical pharmacy","volume":"31","author":"Nyman","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejca.2020.03.026_bib54","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12603-012-0072-6","article-title":"Glomerular filtration rate estimated by Cockcroft-Gault formula better predicts anti-Xa levels than modification of the diet in renal disease equation in older patients with prophylactic enoxaparin","volume":"16","author":"Dufour","year":"2012","journal-title":"J Nutr Health Aging"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920301763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920301763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:28:04Z","timestamp":1760732884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920301763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":54,"alternative-id":["S0959804920301763"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.03.026","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to determine kidney function in cancer patients?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}